Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2
Mus musculus
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein homooligomer Homooligomer Protein × 4 PDB declaration: tetrameric(4) Consistent with protein copy count | Chain A; UniProt 443–643 Chain B; UniProt 443–643 | Fragment:UNP residues 443-643 | 6SY Uridine-3',5'-cyclic monophosphate × 4 | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION, HANGING DROP;pH 4.6;277 K;200 mM NaCl, 0.1 mM sodium citrate pH 4.6, 13% PEG 400 | Resolution 2.01 Å R-free 0.252 |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 5KHJ | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 1Q3E HCN2J 443-645 in the presence of cGMP Deposited 2003-07-29 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
443–645(203 aa)
Fragment:Residues 443-645 (Reference sequence numbering)
|
Not recorded | PCG CYCLIC GUANOSINE MONOPHOSPHATE × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;277 K;PEG 400, sodium citrate, sodium chloride, DTT, HEPES, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.90 Å R-free 0.239 |
| 1Q3E HCN2J 443-645 in the presence of cGMP Deposited 2003-07-29 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain B
443–645(203 aa)
Fragment:Residues 443-645 (Reference sequence numbering)
|
Not recorded | PCG CYCLIC GUANOSINE MONOPHOSPHATE × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;277 K;PEG 400, sodium citrate, sodium chloride, DTT, HEPES, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.90 Å R-free 0.239 |
| 1Q3E HCN2J 443-645 in the presence of cGMP Deposited 2003-07-29 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein homooligomer Homooligomer;Protein × 8 PDB declaration: octameric |
Chain A
443–645(203 aa)
Fragment:Residues 443-645 (Reference sequence numbering)
Chain B
443–645(203 aa)
Fragment:Residues 443-645 (Reference sequence numbering)
|
Not recorded | PCG CYCLIC GUANOSINE MONOPHOSPHATE × 8 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;277 K;PEG 400, sodium citrate, sodium chloride, DTT, HEPES, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.90 Å R-free 0.239 |
| 1Q43 HCN2I 443-640 in the presence of cAMP, selenomethionine derivative Deposited 2003-08-01 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
443–645(203 aa)
Fragment:residues 443-645
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | CMP ADENOSINE-3',5'-CYCLIC-MONOPHOSPHATE × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;277 K;PEG 400, sodium citrate, sodium chloride, DTT, HEPES, cAMP, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.00 Å R-free 0.242 |
| 1Q43 HCN2I 443-640 in the presence of cAMP, selenomethionine derivative Deposited 2003-08-01 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain B
443–645(203 aa)
Fragment:residues 443-645
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | CMP ADENOSINE-3',5'-CYCLIC-MONOPHOSPHATE × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;277 K;PEG 400, sodium citrate, sodium chloride, DTT, HEPES, cAMP, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.00 Å R-free 0.242 |
| 1Q43 HCN2I 443-640 in the presence of cAMP, selenomethionine derivative Deposited 2003-08-01 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein homooligomer Homooligomer;Protein × 8 PDB declaration: octameric |
Chain A
443–645(203 aa)
Fragment:residues 443-645
Chain B
443–645(203 aa)
Fragment:residues 443-645
|
Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) | CMP ADENOSINE-3',5'-CYCLIC-MONOPHOSPHATE × 8 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;277 K;PEG 400, sodium citrate, sodium chloride, DTT, HEPES, cAMP, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.00 Å R-free 0.242 |
| 1Q43 HCN2I 443-640 in the presence of cAMP, selenomethionine derivative Deposited 2003-08-01 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain B
443–645(203 aa)
Fragment:residues 443-645
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | CMP ADENOSINE-3',5'-CYCLIC-MONOPHOSPHATE × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;277 K;PEG 400, sodium citrate, sodium chloride, DTT, HEPES, cAMP, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.00 Å R-free 0.242 |
| 1Q5O HCN2J 443-645 in the presence of cAMP, selenomethionine derivative Deposited 2003-08-08 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
443–645(203 aa)
Fragment:Residues 443-645
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | CMP ADENOSINE-3',5'-CYCLIC-MONOPHOSPHATE × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;277 K;PEG 400, sodium citrate, sodium chloride, DTT, HEPES, cAMP, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.30 Å R-free 0.261 |
| 2Q0A Structure and rearrangements in the carboxy-terminal region of SpIH channels Deposited 2007-05-21 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
443–640(198 aa)
Fragment:C-TERMINAL DOMAIN (residues 443-640)
|
Mutation:I636D | PCG CYCLIC GUANOSINE MONOPHOSPHATE × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;277 K;10 % w/v PEG 8000, 0.5 M NaCl, 15 % Glycerol, 0.1 M MES, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.25 Å R-free 0.261 |
| 2Q0A Structure and rearrangements in the carboxy-terminal region of SpIH channels Deposited 2007-05-21 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain B
443–640(198 aa)
Fragment:C-TERMINAL DOMAIN (residues 443-640)
|
Mutation:I636D | PCG CYCLIC GUANOSINE MONOPHOSPHATE × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;277 K;10 % w/v PEG 8000, 0.5 M NaCl, 15 % Glycerol, 0.1 M MES, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.25 Å R-free 0.261 |
| 2Q0A Structure and rearrangements in the carboxy-terminal region of SpIH channels Deposited 2007-05-21 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein homooligomer Homooligomer;Protein × 8 PDB declaration: octameric |
Chain A
443–640(198 aa)
Fragment:C-TERMINAL DOMAIN (residues 443-640)
Chain B
443–640(198 aa)
Fragment:C-TERMINAL DOMAIN (residues 443-640)
|
Mutation:I636D Mutation:I636D | PCG CYCLIC GUANOSINE MONOPHOSPHATE × 8 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;277 K;10 % w/v PEG 8000, 0.5 M NaCl, 15 % Glycerol, 0.1 M MES, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.25 Å R-free 0.261 |
| 2Q0A Structure and rearrangements in the carboxy-terminal region of SpIH channels Deposited 2007-05-21 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain B
443–640(198 aa)
Fragment:C-TERMINAL DOMAIN (residues 443-640)
|
Mutation:I636D | PCG CYCLIC GUANOSINE MONOPHOSPHATE × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;277 K;10 % w/v PEG 8000, 0.5 M NaCl, 15 % Glycerol, 0.1 M MES, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.25 Å R-free 0.261 |
| 3BPZ HCN2-I 443-460 E502K in the presence of cAMP Deposited 2007-12-19 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
443–640(198 aa)
Fragment:ligand biding domain (residues 443-640)
Chain B
443–640(198 aa)
Fragment:ligand biding domain (residues 443-640)
Chain C
443–640(198 aa)
Fragment:ligand biding domain (residues 443-640)
Chain D
443–640(198 aa)
Fragment:ligand biding domain (residues 443-640)
|
Mutation:E502K Mutation:E502K Mutation:E502K Mutation:E502K | CMP ADENOSINE-3',5'-CYCLIC-MONOPHOSPHATE × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 4.6;279 K;PEG 400, SODIUM CITRATE, SODIUM CHLORIDE, DTT, HEPES, 5 mM CAMP, pH 4.6, VAPOR DIFFUSION, temperature 279K
|
Resolution 1.65 Å R-free 0.216 |
| 3ETQ X-ray structure of cysteine-free fragment of mHCN2 C-terminal region from amino acids 443-630 including C508N, C584S, and C601S mutations Deposited 2008-10-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 8 PDB declaration: octameric |
Chain A
443–640(198 aa)
Fragment:C-terminal fragment
Chain B
443–640(198 aa)
Fragment:C-terminal fragment
|
Mutation:C508N, C584S, C601S Mutation:C508N, C584S, C601S | CMP ADENOSINE-3',5'-CYCLIC-MONOPHOSPHATE × 8 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;277 K;16% w/v PEG 6000, 500 mM NaCl, 10% glycerol, 100 mM citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.90 Å R-free 0.216 |
| 3FFQ HCN2I 443-640 apo-state Deposited 2008-12-04 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
443–640(198 aa)
|
Not recorded | BR BROMIDE ION × 20 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;Two uL protein (5-7 mg/mL) mixed with one uL reservoir solution composed of 0.4 M NaCl, 0.1 NaBr, 0.1 M MES, pH 6.0, 20% glycerol (v/v), and 20% PEG 8000 (w/v). Crystals grew within eight weeks and harvested an additional eight weeks after initial growth, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.40 Å R-free 0.283 |
| 3FFQ HCN2I 443-640 apo-state Deposited 2008-12-04 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain B
443–640(198 aa)
|
Not recorded | BR BROMIDE ION × 16 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;Two uL protein (5-7 mg/mL) mixed with one uL reservoir solution composed of 0.4 M NaCl, 0.1 NaBr, 0.1 M MES, pH 6.0, 20% glycerol (v/v), and 20% PEG 8000 (w/v). Crystals grew within eight weeks and harvested an additional eight weeks after initial growth, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.40 Å R-free 0.283 |
| 4EQF Trip8b-1a#206-567 interacting with the carboxy-terminal seven residues of HCN2 Deposited 2012-04-18 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
857–863(7 aa)
Fragment:UNP residues 857-863
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;298 K;91mM MES, 91mM triSodium citrate, 3.63M NaCL, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 3.00 Å R-free 0.281 |
| 5JON Crystal structure of the unliganded form of HCN2 CNBD Deposited 2016-05-02 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
494–640(147 aa)
|
Not recorded | NO3 NITRATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;34-36% dimethyl PEG 500, 240 mM potassium nitrate, 20 mM magnesium chloride, 100 mM BIS-TRIS, pH 6.0
|
Resolution 2.04 Å R-free 0.221 |
| 5JON Crystal structure of the unliganded form of HCN2 CNBD Deposited 2016-05-02 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric |
Chain B
494–640(147 aa)
|
Not recorded | NO3 NITRATE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;34-36% dimethyl PEG 500, 240 mM potassium nitrate, 20 mM magnesium chloride, 100 mM BIS-TRIS, pH 6.0
|
Resolution 2.04 Å R-free 0.221 |
| 5KHG HCN2 CNBD in complex with cytidine-3', 5'-cyclic monophosphate (cCMP) Deposited 2016-06-14 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
443–643(201 aa)
Fragment:UNP residues 443-643
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | CC7 4-amino-1-[(2S,4aR,6R,7R,7aS)-2,7-dihydroxy-2-oxidotetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]pyrimidin-2(1H)-one × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;277 K;200 mM NaCl, 0.1 mM sodium citrate pH 5.0, 16% PEG 400
|
Resolution 2.24 Å R-free 0.264 |
| 5KHH HCN2 CNBD in complex with inosine-3', 5'-cyclic monophosphate (cIMP) Deposited 2016-06-14 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
443–643(201 aa)
Fragment:UNP residues 443-643
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | 6SW Inosine-3',5'-cyclic monophosphate × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;277 K;200 mM NaCl, 0.1 mM sodium citrate pH 5.5, 14.5% PEG 400
|
Resolution 1.77 Å R-free 0.263 |
| 5KHI HCN2 CNBD in complex with purine riboside-3', 5'-cyclic monophosphate (cPuMP) Deposited 2016-06-14 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
443–643(201 aa)
Fragment:UNP residues 443-643
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | 6SX Purine riboside-3',5'-cyclic monophosphate × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;277 K;200 mM NaCl, 0.1 mM sodium citrate pH 5.5, 18% PEG 400
|
Resolution 2.10 Å R-free 0.249 |
| 5KHK HCN2 CNBD in complex with 2-aminopurine riboside-3', 5'-cyclic monophosphate (2-NH2-cPuMP) Deposited 2016-06-14 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
443–643(201 aa)
Fragment:UNP residues 443-643
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | 6SZ 2-Aminopurine riboside-3',5'-cyclic monophosphate × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;277 K;200 mM NaCl, 0.1 mM sodium citrate pH 4.6, 12% PEG 400
|
Resolution 2.07 Å R-free 0.261 |
| 9R1T Structure of the human chimera HCN112 hyperpolarization-activated cyclic nucleotide-gated ion channel in complex with cAMP. Deposited 2025-04-28 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
444–647(204 aa)
Chain B
444–647(204 aa)
Chain C
444–647(204 aa)
Chain D
444–647(204 aa)
|
Not recorded | CMP ADENOSINE-3',5'-CYCLIC-MONOPHOSPHATE × 4 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.34 Å |
14 other PDB entries and 24 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | HCN2_MOUSE |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 4–204; UniProt 443–643 Author chain B; PDBConstruct 4–204; UniProt 443–643 |